Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Medulloblastoma × Digoxin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Breast Neoplasms 4 Melanoma 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Healthy Participants 2 Advanced Solid Tumor 2 cMET-dysregulated Advanced Solid Tumors 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Solid Tumor, Adult 1 Solid Tumor 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Medulloblastoma 1 Liver Cirrhosis 1 Leukemia, Myeloid, Acute 1 Leiomyosarcoma 1 Head and Neck Neoplasms 1 Drug-drug Interaction,SHR3680 1 Colorectal Neoplasms 1 Advanced Solid Malignancies 1 Advanced Pancreatic Cancer 1

Interventions

Cyclophosphamide 35 Temozolomide 33 Filgrastim 26 Etoposide 26 Carboplatin 25 Vincristine 22 Cisplatin 22 Radiotherapy 20 Magnetic Resonance Spectroscopy 18 Thiotepa 14 Irinotecan 13 Granulocyte Colony-Stimulating Factor 12 Peripheral Blood Stem Cell Transplantation 11 Lomustine 11 Specimen Handling 9 Radiation 9 Melphalan 9 etoposide phosphate 8 Topotecan 8 Methotrexate 8 X-Rays 7 Platinum 7 Phantoms, Imaging 7 sonidegib 6 Biopsy 6 1,2-diaminocyclohexaneplatinum II citrate 6 sargramostim 5 palbociclib 5 Nuclear Medicine Department, Hospital 5 HhAntag691 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06701812 2026-02-27

Digoxin Medulloblastoma Study

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡